ProfileGDS4516 / 208327_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 53% 55% 55% 54% 54% 56% 59% 48% 61% 52% 53% 53% 58% 54% 57% 54% 55% 57% 54% 57% 62% 55% 57% 52% 55% 51% 55% 56% 55% 53% 58% 57% 55% 64% 55% 52% 54% 53% 64% 52% 57% 58% 55% 53% 55% 53% 51% 53% 53% 55% 55% 56% 54% 53% 49% 49% 52% 54% 52% 62% 59% 54% 53% 51% 51% 46% 50% 48% 56% 51% 52% 54% 54% 53% 58% 59% 52% 59% 55% 50% 57% 55% 48% 52% 47% 53% 54% 62% 51% 57% 54% 59% 49% 53% 56% 59% 59% 52% 54% 57% 55% 55% 51% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]5.6094653
GSM537345patient 119, cancer, LCM [OPG study]5.7101855
GSM537355patient 138, cancer, LCM [OPG study]5.770955
GSM537366patient 154, cancer, LCM [OPG study]5.6655254
GSM537370patient 022, cancer, LCM [OPG study]5.6663854
GSM537380patient 037, cancer, LCM [OPG study]5.8076256
GSM537392patient 077, cancer, LCM [OPG study]6.0004459
GSM537415patient 032, cancer, LCM [OPG study]5.2392848
GSM537417patient 042, cancer, LCM [OPG study]6.1676861
GSM537422patient 059, cancer, LCM [OPG study]5.5320452
GSM537423patient 064, cancer, LCM [OPG study]5.6296653
GSM537427patient 084, cancer, LCM [OPG study]5.5763153
GSM537430patient 090, cancer, LCM [OPG study]5.9807158
GSM537336patient 107, cancer, LCM [OPG study]5.644854
GSM537337patient 108, cancer, LCM [OPG study]5.8375457
GSM537348patient 124, cancer, LCM [OPG study]5.6515154
GSM537349patient 125, cancer, LCM [OPG study]5.7321555
GSM537356patient 139, cancer, LCM [OPG study]5.8339457
GSM537361patient 147, cancer, LCM [OPG study]5.6847854
GSM537374patient 026, cancer, LCM [OPG study]5.8659157
GSM537377patient 033, cancer, LCM [OPG study]6.2161562
GSM537378patient 034, cancer, LCM [OPG study]5.7003855
GSM537379patient 036, cancer, LCM [OPG study]5.8894857
GSM537383patient 046, cancer, LCM [OPG study]5.5338452
GSM537388patient 063, cancer, LCM [OPG study]5.7868555
GSM537395patient 082, cancer, LCM [OPG study]5.4268951
GSM537400patient 099, cancer, LCM [OPG study]5.7536855
GSM537404patient 129, cancer, LCM [OPG study]5.8068256
GSM537409patient 141, cancer, LCM [OPG study]5.7384555
GSM537418patient 044, cancer, LCM [OPG study]5.5511353
GSM537425patient 070, cancer, LCM [OPG study]5.9394658
GSM537333patient 102, cancer, LCM [OPG study]5.8773257
GSM537342patient 116, cancer, LCM [OPG study]5.714755
GSM537347patient 123, cancer, LCM [OPG study]6.3321664
GSM537350patient 127, cancer, LCM [OPG study]5.7796455
GSM537362patient 148, cancer, LCM [OPG study]5.5329252
GSM537363patient 150, cancer, LCM [OPG study]5.6773754
GSM537368patient 156, cancer, LCM [OPG study]5.6210853
GSM537376patient 031, cancer, LCM [OPG study]6.3720964
GSM537381patient 038, cancer, LCM [OPG study]5.5580752
GSM537386patient 057, cancer, LCM [OPG study]5.8374257
GSM537398patient 094, cancer, LCM [OPG study]5.9186958
GSM537402patient 109, cancer, LCM [OPG study]5.7173655
GSM537405patient 130, cancer, LCM [OPG study]5.6303253
GSM537371patient 023, cancer, LCM [OPG study]5.6989755
GSM537421patient 055, cancer, LCM [OPG study]5.5926353
GSM537424patient 065, cancer, LCM [OPG study]5.5393951
GSM537432patient 097, cancer, LCM [OPG study]5.5963453
GSM537331patient 100, cancer, LCM [OPG study]5.603853
GSM537332patient 101, cancer, LCM [OPG study]5.7456355
GSM537334patient 103, cancer, LCM [OPG study]5.7652455
GSM537338patient 110, cancer, LCM [OPG study]5.7941756
GSM537353patient 135, cancer, LCM [OPG study]5.6505754
GSM537357patient 142, cancer, LCM [OPG study]5.6028553
GSM537358patient 143, cancer, LCM [OPG study]5.3477749
GSM537375patient 030, cancer, LCM [OPG study]5.3924949
GSM537389patient 068, cancer, LCM [OPG study]5.4931452
GSM537390patient 072, cancer, LCM [OPG study]5.6394754
GSM537393patient 078, cancer, LCM [OPG study]5.5217152
GSM537399patient 095, cancer, LCM [OPG study]6.2302762
GSM537407patient 133, cancer, LCM [OPG study]6.0220659
GSM537408patient 140, cancer, LCM [OPG study]5.6665754
GSM537428patient 086, cancer, LCM [OPG study]5.6359453
GSM537354patient 136, cancer, LCM [OPG study]5.4340651
GSM537410patient 146, cancer, LCM [OPG study]5.499951
GSM537413patient 027, cancer, LCM [OPG study]5.1489846
GSM537396patient 083, cancer, LCM [OPG study]5.4310650
GSM537397patient 088, cancer, LCM [OPG study]5.3120748
GSM537330patient 006, cancer, LCM [OPG study]5.7807956
GSM537369patient 015, cancer, LCM [OPG study]5.4837851
GSM537373patient 025, cancer, LCM [OPG study]5.5313152
GSM537401patient 106, cancer, LCM [OPG study]5.6777154
GSM537343patient 117, cancer, LCM [OPG study]5.6567254
GSM537367patient 155, cancer, LCM [OPG study]5.5964153
GSM537382patient 041, cancer, LCM [OPG study]5.9601458
GSM537385patient 053, cancer, LCM [OPG study]6.0087259
GSM537391patient 073, cancer, LCM [OPG study]5.5530752
GSM537419patient 045, cancer, LCM [OPG study]6.0262459
GSM537420patient 052, cancer, LCM [OPG study]5.7796555
GSM537429patient 089, cancer, LCM [OPG study]5.3728450
GSM537431patient 096, cancer, LCM [OPG study]5.9272657
GSM537387patient 061, cancer, LCM [OPG study]5.74255
GSM537414patient 028, cancer, LCM [OPG study]5.2315948
GSM537433patient 098, cancer, LCM [OPG study]5.5571652
GSM537335patient 104, cancer, LCM [OPG study]5.1876447
GSM537339patient 111, cancer, LCM [OPG study]5.5818553
GSM537340patient 113, cancer, LCM [OPG study]5.6869954
GSM537344patient 118, cancer, LCM [OPG study]6.1794662
GSM537346patient 011, cancer, LCM [OPG study]5.4644751
GSM537351patient 128, cancer, LCM [OPG study]5.8920557
GSM537352patient 134, cancer, LCM [OPG study]5.6751654
GSM537359patient 144, cancer, LCM [OPG study]5.9904459
GSM537360patient 145, cancer, LCM [OPG study]5.3633449
GSM537364patient 152, cancer, LCM [OPG study]5.6230353
GSM537365patient 153, cancer, LCM [OPG study]5.7651456
GSM537372patient 024, cancer, LCM [OPG study]6.0390359
GSM537384patient 048, cancer, LCM [OPG study]6.0171359
GSM537394patient 081, cancer, LCM [OPG study]5.5399252
GSM537403patient 121, cancer, LCM [OPG study]5.704454
GSM537406patient 131, cancer, LCM [OPG study]5.890957
GSM537411patient 149, cancer, LCM [OPG study]5.7720755
GSM537412patient 019, cancer, LCM [OPG study]5.773855
GSM537416patient 035, cancer, LCM [OPG study]5.4628851
GSM537426patient 079, cancer, LCM [OPG study]5.4579351